4//SEC Filing
Chung Jane 4
Accession 0001872398-25-000005
CIK 0001382101other
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 8:47 PM ET
Size
16.9 KB
Accession
0001872398-25-000005
Insider Transaction Report
Form 4
Chung Jane
PRESIDENT AND COO
Transactions
- Exercise/Conversion
Common Stock
2025-12-12+2,500→ 14,785 total - Tax Payment
Common Stock
2025-12-12$8.02/sh−894$7,165→ 13,891 total - Exercise/Conversion
Restricted Stock Unit (RSU)
2025-12-12−2,500→ 5,000 totalExp: 2027-12-01→ Common Stock (2,500 underlying)
Footnotes (3)
- [F1]Represents the number of shares of Common Stock that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of RSUs; does not represent a sale by the reporting person.
- [F2]Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.
- [F3]The RSU award vested or vests as to 1/4th of the total award annually, subject to continued service through each vesting date, with the first tranche vested on December 1, 2024. The reported transaction represents the deferred vesting and settlement of a tranche of this award pursuant to the terms of the reporting person's award agreement with the Issuer.
Documents
Issuer
SUTRO BIOPHARMA, INC.
CIK 0001382101
Entity typeother
Related Parties
1- filerCIK 0001872398
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 8:47 PM ET
- Size
- 16.9 KB